Professor Dr. Ernst von Schwarz MD, PHD, FESC, FACC, FSCAI is a US based world renowned, triple board certified clinical and academic cardiologist and clinical professor of medicine at UCLA and UC Riverside. He joined Cedars Sinai Medical Center and UCLA as Director of the Cardiac Device Program in 2006, he was appointed director of cardiology at the Heart Institute of Southern California Hospital Culver City in 2015 and chairman of Pacific Heart Medical Group and medical director of Heart Stem Inc. in 2016.
He is considered a worldwide pioneer in the field of stem cell research. He has published over 150 scientific papers in international peer reviewed medical journals, as well as several books and book chapters in cardiovascular medicine. He is a sought after expert witness in several high profile court cases, and a regular medical news contributor to TV and radio. Dr. von Schwarz is a prolific speaker lecturing worldwide at international scientific conferences including American Heart Association, American College of Cardiology, and the European Society of Cardiology.
Dr. Ernst von Schwarz is a regular medical news expert and contributor for the most‑watched TV news network.
Early Life
Dr. von Schwarz was born in Kassel, Germany, as the second child of Ernest Johann Ferdinand von Schwarz an academic economist trained at the Universities of Prague and Pilsen, and his wife Elise Frieda Reiss, a government employee. His older sister, Eva Regina, is a High Court Federal Judge in Nuremberg, Germany.
Dr. von Schwarz studies medicine at the University of Vienna, Austria and the Philipps University Marburg, Germany, and the University of Ife, Ile-Ife, Nigeria.
In 1989, he wrote his thesis on pepsin secretion in the stomach and was awarded his doctorate degree at the Philipps University Marburg, Germany. In 1991, he was awarded his second doctorate degree from the University of Vienna, Austria.
Shortly thereafter, he was a scholar of the German Heart Foundation and worked as a research fellow at the Max Planck Institute for Experimental Cardiology under Prof. Dr. Wolfgang Schaper in Bad Nauheim, Germany, and later at the University of Southern California, Los Angeles with Prof. Dr. Robert Kloner on experimental models of cardiac protection in myocardial ischemia, which he continued during his 10 year tenure at the University Hospital of the RWTH University of Technology in Aachen, Germany. In 1999, he finished his thesis (“Habilitation”) for his Professorship on research on myocardial bridges, a frequent coronary anomaly.
Dr. Ernst von Schwarz, standing row, first left, 1977
Career
Dr. von Schwarz worked as interventional cardiologist and directed the heart transplant program at the University Hospital of the RWTH University of Technology in Aachen, Germany.
From 2000-2003, Dr. von Schwarz worked as the Chairman of Cardiology at the Fakeeh Hospital (a Harvard Medical International facility) in Jeddah, Saudi Arabia.
From 2003-2006, he worked as Professor of Medicine and Director of the Cardiology Clinics and the Heart Transplant Section at the University of Texas UTMB in Galveston, Texas.
In 2006, he joined Cedars Sinai Medical Center and UCLA as Professor of Medicine and Director of the Cardiac Device Program.
In 2015, he became Director of Cardiology at the Heart Institute at Southern California Hospital in Culver City.
In 2016, Dr. von Schwarz became Chairman of Pacific Heart Medical Group in Murrieta, California as well as the Medical Director of Heart Stem Inc.
Dr. von Schwarz is the author of numerous scientific articles on experimental and clinical cardiology, cardiac protection and sexual dysfunction in heart disease as well as of books such as “Erectile Dysfunction”, Oxford University Press in 2016, “Sex and the Heart” in 2007, and several book chapters in medic such as “Cardiology for the Primary Care Physician”, “Right Heart Pathology” in 2019, among many others.
Dr. von Schwarz has published over 150 scientific papers and is a prolific speaker lecturing worldwide on advances in research in cardiology, sexual dysfunction, and the aspects of aging and modern stem cell therapy.
